Dextrose Monohydrate 5% Injection — FDA Drug Shortage

Current — Fresenius Kabi USA, LLC

The FDA lists a drug shortage record for Dextrose Monohydrate 5% Injection (injection) from Fresenius Kabi USA, LLC with status Current. The shortage was first posted on Feb 14, 2022. Reported reason: Demand increase for the drug

Shortage details

Status
Current
Company
Fresenius Kabi USA, LLC
Package NDC
65219-458-30
Dosage Form
Injection
Presentation
Dextrose 5% In Plastic Container, Injection, 50 mg/1 mL (NDC 65219-458-30)
Initial Posting
Feb 14, 2022

Reason

Demand increase for the drug

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.